Habeo Cell Therapy (ECCS-50) - Plus Therap
Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds (clinicaltrials.gov) - Sep 25, 2019 - P=N/A; N=15; Suspended; Sponsor: Cytori Therapeutics; Recruiting ➔ Suspended 
Clinical • Trial suspension
http://clinicaltrials.gov/ct2/show/NCT03435172
 
Sep 25, 2019
 
Prev Next